Pleural complications and chest tube follow-up in patients with COVID-19

dc.authoridBatıhan, Güntuğ/0000-0001-5258-2856
dc.authoridYazgan, Serkan/0000-0001-9763-6336
dc.authoridKirakli, Cenk/0000-0001-6013-7330
dc.authorwosidBatıhan, Güntuğ/AAS-4733-2020
dc.authorwosidYazgan, Serkan/GSO-1911-2022
dc.authorwosidKirakli, Cenk/AAE-2202-2020
dc.contributor.authorCeylan, Kenan Can
dc.contributor.authorBatıhan, Güntuğ
dc.contributor.authorYazgan, Serkan
dc.contributor.authorGürsoy, Soner
dc.contributor.authorKıraklı, Sami Cenk
dc.contributor.authorAtaman, Sena
dc.date.accessioned2023-03-22T19:47:33Z
dc.date.available2023-03-22T19:47:33Z
dc.date.issued2021
dc.departmentBelirleneceken_US
dc.description.abstractIntroduction: It was reported that the SARS-CoV-2 virus primarily affects the lower respiratory system and various pleural complications may accompany coronavirus disease 2019 (COVID-19). Aims and objectives: We aimed to present the characteristics of patients who underwent a chest tube insertion due to pleural complications during COVID-19 disease and the technique we developed to minimize possible contamination from the underwater seal bottle in these patients. Methods: We retrospectively examined the characteristics of patients who developed pleural complications during COVID-19 disease in our hospital between March 11 and May 15, 2020. Results: Between March 11 and May 15, 2020, a total of 342 patients were hospitalized with the diagnosis of COVID-19. Tube thoracostomy was performed in 13 (%3.8) of these patients due to pleural complications. Indications for chest tube placement were: Pneumothorax in six (%46.1) patients, pleural effusion in three (%23) patients, empyema in three (%23) patients, and hemothorax in one patient (%7.6). A high-efficiency particulate air (HEPA) viral filter mounted two bottle technique was used in the follow-up of chest drains en_US
dc.identifier.doi10.1183/13993003.congress-2021.PA438
dc.identifier.issn0903-1936
dc.identifier.issn1399-3003
dc.identifier.urihttps://doi.org/10.1183/13993003.congress-2021.PA438
dc.identifier.urihttps://hdl.handle.net/20.500.14034/764
dc.identifier.volume58en_US
dc.identifier.wosWOS:000747452105344en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherEuropean Respiratory Soc Journals Ltden_US
dc.relation.journalEuropean Respiratory Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCovid-19en_US
dc.subjectPleuraen_US
dc.subjectTreatmentsen_US
dc.titlePleural complications and chest tube follow-up in patients with COVID-19en_US
dc.typeConference Objecten_US

Dosyalar